|Podcasts|September 15, 2011
INC's CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC's own role and strategy in its recent acquisitions.
Advertisement
INC’s CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC’s own role and strategy in its recent acquisitions.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway
2
Where AI Is Delivering Real Value in Clinical Trial Payments Right Now
3
ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems
4
From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance
5